Gene · 27022
Papers1,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,402
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| VISTA is a potential target for immunotherapy in B-cell acute lymphoblastic leukemia in children. | Sci Rep | 2025 | 40610562 | PubTator, text mining | PubMed |
| FOXD3 promotes homologous recombination repair and genomic stability by facilitating MRE11-mediated DNA end resection. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 40515531 | PubTator, text mining | PubMed |
| RETRACTION: Nanos2 Promotes Differentiation of Male Germ Cells Basing on the Negative Regulation of Foxd3 and the Treatment of 5-Azadc and TSA. | J Cell Physiol | 2025 | 40415732 | PubTator, text mining | PubMed |
| Transcription Factor FOXD3 Regulates ELAV1/TLR4 Axis in Antiphospholipid Syndrome to Mediate Proliferation and Migration of Trophoblasts. | Mol Reprod Dev | 2025 | 40165384 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Congenital Aniridia and Differential Diagnoses: Genetic Insights and Clinical Manifestations. | Ophthalmol Ther | 2025 | 40138169 | PubTator, text mining | PubMed |
| Long noncoding RNA as an emerging regulator of endoderm differentiation: progress and perspectives. | Cell Regen | 2025 | 40133743 | PubTator, text mining | PubMed |
| Bacteroides fragilis Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel Disease. | J Crohns Colitis | 2025 | 40065724 | PubTator, text mining | PubMed |
| Identification of a novel non-coding deletion in Allan-Herndon-Dudley syndrome by long-read HiFi genome sequencing. | BMC Med Genomics | 2025 | 40033291 | PubTator, text mining | PubMed |
| Exploring the molecular characterization of PANoptosis-related genes with features of immune dysregulation in Alzheimer's disease based on bulk and single-nuclei RNA sequencing. | Metab Brain Dis | 2025 | 39841296 | PubTator, text mining | PubMed |
| Genetic Insights into Facial Variation and Craniofacial Development: Unraveling the Interplay of Genes, Expression Patterns, and Evolutionary Significance. | Mol Biotechnol | 2025 | 39724323 | PubTator, text mining | PubMed |
| Foxd3/SLC5A6 axis regulates apoptosis in LUAD cells by controlling mitochondrial biotin uptake. | Cell Signal | 2025 | 39426496 | PubTator, text mining | PubMed |
| Formation of CSE-YAP complex drives FOXD3-mediated transition of neurotoxic astrocytes in Parkinson's disease. | Pharmacol Res | 2024 | 39547464 | PubTator, text mining | PubMed |
| Forkhead box D subfamily genes in colorectal cancer: potential biomarkers and therapeutic targets. | PeerJ | 2024 | 39494294 | PubTator, text mining | PubMed |
| Corrigendum: LncRNA FOXD3-AS1 promotes the malignant progression of nasopharyngeal carcinoma through enhancing the transcription of YBX1 by H3K27Ac modification. | Front Oncol | 2024 | 38919529 | PubTator, text mining | PubMed |
| Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition. | Front Oncol | 2024 | 38854737 | PubTator, text mining | PubMed |
| The oxidative stress-associated long non-coding RNAs in pancreatic cancer. | Adv Med Sci | 2024 | 38670228 | PubTator, text mining | PubMed |
| Substrate Stiffness Modulates Stemness and Differentiation of Rabbit Corneal Endothelium Through the Paxillin-YAP Pathway. | Invest Ophthalmol Vis Sci | 2024 | 38466286 | PubTator, text mining | PubMed |
| Investigation of the differentiation potential of pericyte cells as an alternative source of mesenchymal stem cells. | Acta Histochem | 2024 | 38432161 | PubTator, text mining | PubMed |
| Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review. | Int J Mol Sci | 2024 | 38255778 | PubTator, text mining | PubMed |
| Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma. | iScience | 2024 | 38222111 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27022/papers?page=2